Furen Group Pharmaceutical Co.,Ltd. Posted 604.8 Million Yuan Net Loss in First Three Quarters of 2022

Furen Group Pharmaceutical Co.,Ltd. (辅仁药业集团制药股份有限公司) (600781.SH) reported a net loss of 604.8 million yuan in the first three quarters of 2022, widening 9.5% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, down 13.3% year-on-year.

At the end of the reporting period, it had 8.2 billion yuan in total assets and 8.1 billion yuan in total liabilities, with a liability-to-asset ratio of 98.1%.